Biotechnology and the bovine practitioner

Authors

  • Karen L. Jacobsen Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602; Department of Medical Microbiology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602

DOI:

https://doi.org/10.21423/bovine-vol0no22p18-20

Keywords:

Biotechnology, cattle diseases, Interleukins, Monoclonal antibodies, Recombinant DNA, Vaccines, Veterinary practice

Abstract

There is clearly a revolution going on in the methodology which is used to develop new diagnostics, prophylactics and therapeutics for human and veterinary medicine. It is fortunate for the bovine practitioner that many of the first veterinary products developed using new biotechnology techniques have been for use in cattle. The possibilities for future veterinary products derived by these methods will be limited only by the financial and time resources committed to such endeavors by public research institutions and private industry.

Cover image of the 22nd Volume of the Bovine Practitioner: a photo of Phoenix's Capitol Mall from the vantage point of the dome of the Arizona Capitol dome, with the statue of Winged Victory taking visual prominence.

Downloads

Published

1987-11-01

How to Cite

Jacobsen, K. L. (1987). Biotechnology and the bovine practitioner. The Bovine Practitioner, (22), 18–20. https://doi.org/10.21423/bovine-vol0no22p18-20

Issue

No. 22 (1987 November)

Section

Articles